Tansna Therapeutics

tansna.com

Total Raised

$850K

Investors Count

3

Funding, Valuation & Revenue

3 Fundings

Tansna Therapeutics has raised $850K over 3 rounds.

Tansna Therapeutics's latest funding round was a Seed VC for $0.67M on March 5, 2015.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

3/5/2015

Seed VC

$0.67M

$XXM

0

FY undefined

1

2/19/2013

Pre-Seed

$XXM

0

FY undefined

10

9/30/2011

Grant

$XXM

$XXM

0

FY undefined

10

Date

3/5/2015

2/19/2013

9/30/2011

Round

Seed VC

Pre-Seed

Grant

Amount

$0.67M

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

Start free trial
New call-to-action

Tansna Therapeutics Investors

3 Investors

Tansna Therapeutics has 3 investors. iSelect Fund invested in Tansna Therapeutics's Seed VC funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

3/5/2015

3/5/2015

1
Seed VC

Venture Capital

Missouri

00/00/0000

00/00/0000

BioGenerator

Subscribe to see more

Non-Profit Foundation

Missouri

00/00/0000

00/00/0000

National Institutes of Health

Subscribe to see more

Government

Maryland

First funding

3/5/2015

00/00/0000

00/00/0000

Last Funding

3/5/2015

00/00/0000

00/00/0000

Investor

BioGenerator

National Institutes of Health

Rounds

1
Seed VC

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Non-Profit Foundation

Government

Location

Missouri

Missouri

Maryland

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.